.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Farmers Insurance
Healthtrust
Boehringer Ingelheim
Merck
Chinese Patent Office
Citi
Teva
Cantor Fitzgerald

Generated: June 23, 2017

DrugPatentWatch Database Preview

KENALOG-H Drug Profile

« Back to Dashboard

Which patents cover Kenalog-h, and when can generic versions of Kenalog-h launch?

Kenalog-h is a drug marketed by Delcor Asset Corp and is included in one NDA.

The generic ingredient in KENALOG-H is triamcinolone acetonide. There are fifty drug master file entries for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for Tradename: KENALOG-H

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list49
Clinical Trials: see list29
Patent Applications: see list6,652
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KENALOG-H at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: KENALOG-H

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 19824,048,310► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Citi
Chubb
US Department of Justice
Johnson and Johnson
US Army
Express Scripts
Accenture
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot